Prelude Capital Management’s Innophos Holdings, Inc. IPHS Stock Holding History

Prelude Capital Management’s Portfolio IPHS Stock Details IPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,275	Closed	-$169K	–	2299
2019 Q4	$169K	Buy	+5,275	New	+$170K	0.01%	905
2017 Q4	–	Sell	-400	Closed	-$20K	–	1873
2017 Q3	$20K	Buy	+400	New	+$18K	﹤0.01%	1327
2017 Q1	–	Sell	-659	Closed	-$34K	–	1902
2016 Q4	$34K	Buy	659 +65	+11%	+$3.16K	﹤0.01%	1190
2016 Q3	$23K	Buy	+594	New	+$24.4K	﹤0.01%	1323
2015 Q1	–	Sell	-860	Closed	-$50K	–	2310
2014 Q4	$50K	Buy	+860	New	+$48.3K	0.01%	1239
2013 Q4	–	Sell	-200	Closed	-$11K	–	2046
2013 Q3	$11K	Buy	+200	New	+$10.1K	﹤0.01%	1281

Other funds holding IPHS

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Prelude Capital Management's IPHS Position: Q1 2020 in Review

Prelude Capital Management sold out of Innophos Holdings, Inc. (IPHS) in Q1 2020, closing a stake of 5,275 shares — an estimated $169K sold.

Prelude Capital Management first reported a position in IPHS in Q3 2013 and held it in 6 quarters. The position peaked at $169K in Q4 2019. 2 funds tracked by Wall St. Rank hold IPHS as of Q1 2020.

Prelude Capital Management reported no remaining Innophos Holdings, Inc. position as of Q1 2020 after selling out during the quarter.
Prelude Capital Management sold 5,275 Innophos Holdings, Inc. shares in Q1 2020, an estimated $169K.
Prelude Capital Management first reported a position in Innophos Holdings, Inc. in Q3 2013 and held it in 6 quarters.
Prelude Capital Management's Innophos Holdings, Inc. position peaked at $169K in Q4 2019.
2 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q1 2020.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.